The British Columbia Court of Appeal has affirmed a judgment determining that orders issued under s. 91.11 of division 2.1 of ...

The global ATMPs Consulting Market is expected to witness a healthy and a double-digit growth rate by 2027. The key factors ...

Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...

Tevimbra is currently approved in the EU as a treatment for gastric cancer, esophageal squamous cell cancer and small cell ...

EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN: Stamford, Connecticut Tuesday, May 27, 2025, 12:00 Hr ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

Bayer announces EMA committee recommends label extension approval for Eylea 8 mg: Berlin Monday, May 26, 2025, 17:00 Hrs [IST] Bayer announced that the Committee for Medicinal Pro ...

Duchesnay, member of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, in ...

Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...

Support is at $102,168, and resistance is near $106,655. If BTC breaks $102,168, it could test $100,799 or $99,356. A bullish ...